Viatris Current Ratio 2010-2024 | VTRS

Current and historical current ratio for Viatris (VTRS) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Viatris current ratio for the three months ending March 31, 2024 was 1.67.
Viatris Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $12.92B $7.76B 1.67
2023-12-31 $12.98B $7.78B 1.67
2023-09-30 $10.93B $6.83B 1.60
2023-06-30 $9.78B $6.52B 1.50
2023-03-31 $9.63B $6.11B 1.58
2022-12-31 $10.64B $6.75B 1.58
2022-09-30 $10.49B $6.52B 1.61
2022-06-30 $11.18B $7.68B 1.46
2022-03-31 $11.74B $9.64B 1.22
2021-12-31 $10.90B $9.88B 1.10
2021-09-30 $11.31B $10.10B 1.12
2021-06-30 $11.75B $10.13B 1.16
2021-03-31 $12.32B $9.98B 1.24
2020-12-31 $12.87B $10.56B 1.22
2020-09-30 $7.34B $7.28B 1.01
2020-06-30 $6.47B $6.97B 0.93
2020-03-31 $6.60B $5.23B 1.26
2019-12-31 $6.76B $5.57B 1.21
2019-09-30 $6.65B $4.65B 1.43
2019-06-30 $6.27B $4.56B 1.37
2019-03-31 $6.26B $4.16B 1.51
2018-12-31 $6.37B $4.59B 1.39
2018-09-30 $6.54B $5.18B 1.26
2018-06-30 $6.30B $4.86B 1.30
2018-03-31 $6.76B $6.39B 1.06
2017-12-31 $7.21B $6.39B 1.13
2017-09-30 $7.27B $4.98B 1.46
2017-06-30 $6.97B $5.17B 1.35
2017-03-31 $7.07B $4.52B 1.56
2016-12-31 $7.52B $5.04B 1.49
2016-09-30 $7.97B $9.55B 0.83
2016-06-30 $12.19B $3.78B 3.23
2016-03-31 $6.63B $3.96B 1.67
2015-12-31 $6.47B $4.12B 1.57
2015-09-30 $6.49B $3.68B 1.76
2015-06-30 $7.89B $5.37B 1.47
2015-03-31 $7.43B $5.29B 1.40
2014-12-31 $6.44B $5.30B 1.21
2014-09-30 $5.82B $4.47B 1.30
2014-06-30 $4.48B $2.60B 1.72
2014-03-31 $4.34B $2.65B 1.64
2013-12-31 $4.47B $2.96B 1.51
2013-09-30 $4.34B $2.56B 1.70
2013-06-30 $4.21B $2.33B 1.81
2013-03-31 $3.95B $2.28B 1.73
2012-12-31 $3.90B $2.19B 1.78
2012-09-30 $3.75B $2.17B 1.73
2012-06-30 $3.75B $2.16B 1.73
2012-03-31 $3.74B $2.11B 1.77
2011-12-31 $3.57B $2.56B 1.39
2011-09-30 $3.61B $2.38B 1.52
2011-06-30 $3.76B $2.52B 1.49
2011-03-31 $3.76B $2.39B 1.57
2010-12-31 $3.56B $1.81B 1.97
2010-09-30 $3.46B $1.72B 2.01
2010-06-30 $3.63B $1.63B 2.23
2010-03-31 $3.36B $1.64B 2.05
2009-12-31 $3.29B $1.72B 1.91
2009-09-30 $3.26B $1.58B 2.06
2009-06-30 $3.02B $1.42B 2.13
2009-03-31 $2.91B $1.34B 2.17
Sector Industry Market Cap Revenue
Medical Medical Services $13.931B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $118.753B 14.48
Cencora (COR) United States $45.072B 17.57
ICON (ICLR) Ireland $27.369B 24.59
DiDi Global (DIDIY) China $17.109B 0.00
Avantor (AVTR) United States $15.195B 22.37
CochLear (CHEOY) Australia $14.677B 0.00
Revvity (RVTY) United States $13.772B 24.16
Natera (NTRA) United States $13.029B 0.00
Medpace Holdings (MEDP) United States $11.839B 35.92
Charles River Laboratories (CRL) United States $11.456B 21.93
Solventum (SOLV) United States $10.033B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $9.918B 0.00
Sonic Healthcare (SKHHY) Australia $8.114B 0.00
HealthEquity (HQY) United States $6.801B 43.67
Bausch + Lomb (BLCO) Canada $5.689B 22.77
Organon (OGN) United States $5.563B 5.28
Doximity (DOCS) United States $5.170B 36.21
PACS (PACS) United States $5.142B 0.00
Life Times (LTH) United States $4.112B 43.08
Sotera Health (SHC) United States $3.787B 18.58
Surgery Partners (SGRY) United States $3.772B 34.51
GoodRx Holdings (GDRX) United States $3.366B 128.14
Agilon Health (AGL) United States $2.780B 0.00
Progyny (PGNY) United States $2.664B 45.87
AMN Healthcare Services Inc (AMN) United States $2.344B 9.29
Premier (PINC) United States $2.118B 9.06
BrightSpring Health Services (BTSG) United States $2.063B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.871B 0.00
Alignment Healthcare (ALHC) United States $1.776B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Establishment Labs Holdings (ESTA) $1.315B 0.00
CareDx (CDNA) United States $0.959B 0.00
Embecta (EMBC) United States $0.943B 6.41
GeneDx Holdings (WGS) United States $0.884B 0.00
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.653B 0.00
Pediatrix Medical (MD) United States $0.646B 6.86
Sharecare (SHCR) United States $0.500B 0.00
Enhabit (EHAB) United States $0.498B 49.65
COMPASS Pathways (CMPS) United Kingdom $0.475B 0.00
Sonida Senior Living (SNDA) United States $0.446B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.331B 6.20
DocGo (DCGO) United States $0.330B 18.06
LifeMD (LFMD) United States $0.283B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.258B 0.00
Beauty Health (SKIN) United States $0.224B 0.00
Ascend Wellness Holdings (AAWH) United States $0.207B 0.00
Biodesix (BDSX) United States $0.187B 0.00
So-Young (SY) China $0.097B 47.00
Pono Capital Two (PTWO) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.043B 5.79
Oncology Institute (TOI) United States $0.042B 0.00
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.037B 0.00
Nutex Health (NUTX) United States $0.037B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.023B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.019B 0.00
TRxADE HEALTH (MEDS) United States $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
XWELL (XWEL) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Aclarion (ACON) United States $0.003B 0.00